- Healthcare Acquired Infections Alethia® C. difficile
- Pediatric & Neonatal Alethia® CMV Alethia® Group B Streptococcus
- Respiratory Alethia® Mycoplasma Direct Alethia® Pertussis Alethia® Group A Streptococcus
- Sexual Health Alethia® HSV 1&2
- Tropical Diseases Alethia® Malaria RESEARCH USE ONLY Alethia® Malaria Plus RESEARCH USE ONLY
Molecular assay for the detection of Group A Streptococcus. A quick, accurate and reliable molecular assay for Group A Strep detection.
Catalog Number: 480150
Support & Documents
Webinars & Videos
98% sensitivity means increased detection of positives with fewer false negatives – Eliminates subjectivity related to traditional culture methods – Rapid turn around time in comparison to 48 hours for culture, allowing for proper patient management and appropriate antibiotic treatment.
Traditional culture sensitivity is as low as 90% with optimal technique – Overgrowth of normal flora –
Variability in how the specimen is attained affecting amount of streptococci growth.
Yes, a Flocked Nylon, Polyester, or Rayon swab in either Liquid Stuart or Liquid Amies, without charcoal is appropriate.
Unnecessary antibiotic treatment exposes patients to the expense and hazards which can lead to the development of antimicrobial resistance among common pathogens1. Up to 70% of patients receive antibiotic therapy while only 20%-30% have Group A Strep pharyngitis1. Estimated economic costs of pediatric streptococcal pharyngitis in the U.S. range from $224M to $539M per year.
Alethia® Group A Strep – 87651
1. Shulman et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis:2012 Update by the Infectious Diseases Society of America.
2. Alethia Group A Streptococcus Package Insert, SN11022.